To rule out the possibility that the tumor microenvironment influences how the C6 glioma xenograft responded to MNF, C6 glioma cells in culture were treated with 20 nmol/L MNF for 6 and 24 h, and expression changes in cyclin A and cyclin D1 were evaluated. The gene discussed is CCNA2; the disease is central nervous system cancer.